Global Suppression of IL-6-induced Acute Phase Response Gene Expression after Chronic in Vivo Treatment with the Peroxisome Proliferator-activated Receptor-α Activator Fenofibrate
Open Access
- 1 April 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (16) , 16154-16160
- https://doi.org/10.1074/jbc.m400346200
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Vascular Inflammation Is Negatively Autoregulated by Interaction Between CCAAT/Enhancer-Binding Protein-δ and Peroxisome Proliferator-Activated Receptor-γCirculation Research, 2002
- Effect of Ciprofibrate on C-Reactive Protein and Fibrinogen LevelsAngiology, 2002
- Negative Regulation of Human Fibrinogen Gene Expression by Peroxisome Proliferator-activated Receptor α Agonists via Inhibition of CCAAT Box/Enhancer-binding Protein βJournal of Biological Chemistry, 2001
- Synergistic Activity of STAT3 and c-Jun at a Specific Array of DNA Elements in the α2-Macroglobulin PromoterPublished by Elsevier ,2001
- Essential Role of STAT3 in the Control of the Acute-Phase Response as Revealed by Inducible Gene Activation in the LiverMolecular and Cellular Biology, 2001
- Smad Proteins Suppress CCAAT/Enhancer-binding Protein (C/EBP) β- and STAT3-mediated Transcriptional Activation of the Haptoglobin PromoterJournal of Biological Chemistry, 2001
- gp130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINESAnnual Review of Immunology, 1997
- The PPARα–leukotriene B4 pathway to inflammation controlNature, 1996
- Functional Analysis of IL‐6 and IL‐6DBP/C/EBPβ by Gene TargetingAnnals of the New York Academy of Sciences, 1995
- A viscometric method of measuring plasma fibrinogen concentrations.Journal of Clinical Pathology, 1992